Last reviewed · How we verify

MM36 topical ointment, 1%

Medimetriks Pharmaceuticals, Inc · Phase 2 active Small molecule

At a glance

Generic nameMM36 topical ointment, 1%
Also known asOPA-15406
SponsorMedimetriks Pharmaceuticals, Inc
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results